LSE
0.92GBp
-0.06 (-5.64%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
3M
P/E
—
EPS
—
Beta
1.54
52W range
0.85-17.445
Day range
—
Open
—
Prev close
—
Volume
4.3K
Avg volume
2.4M
Dividend
0.00
IPO
2023-09-25
CelLBxHealth Plc is a holding company, which engages in the provision of its subsidiaries engages in providing products in cancer diagnostics and foetal health. Its main product is the Parsortix cell separation system, which can capture very rare cells from blood. The company was founded by Andrew D. W. Newland in April 1994 and is headquartered in Guildford, the United Kingdom.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about CelLBxHealth plc — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for AGL.L: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
